We use cookies for a better user experience. Read our Privacy Policy
I Agree
Metagenomics Market
Economic activities in the metagenomics market are pacing up due to an unprecedented demand for COVID-19 (coronavirus) drug and vaccine discovery. Scientists have joined forces with metagenomics companies in order to provide tools and information that help if tackling the novel coronavirus. As such, companies in the metagenomics market are increasing their attention toward RNA sequencing-based data. Global leaders in next-generation sequencing services are adopting metagenomics detection of SARS-CoV-2 to effectively manage and analyze possible outcomes of the infection.
Metagenomics analysis platforms are gaining increased popularity in order to conduct metagenomics sequencing. Companies are experimenting with different algorithms for matching the closest genome to the novel coronavirus. They are conducting phylogenetic research to accelerate processes in the genomics community.
To know the scope of our report Get a Sample on Metagenomics Market
Metagenomics next generation sequencing is playing an instrumental role in the diagnosis of meningitis and encephalitis. The New England Journal of Medicine (NEJM) states that metagenomics sequencing is proving its utility in diagnosis of the most challenging cases of neuroinfectious diseases. Companies in the metagenomics market are increasing efforts to collect and analyze samples in real time in order to improve clinical outcomes.
A comprehensive read of the DNA and RNA in clinical samples is becoming possible with metagenomics sequencing. Companies in the metagenomics market are conducting bioinformatic comparison of the DNA and RNA samples with the publicly available databases to seek answers for agents responsible for the progression of neuroinfectious diseases. Metagenomics sequencing is being highly publicized in the healthcare landscape, since there is a high prevalence of infectious diseases that result in meningitis or encephalitis in individuals.
Get a glimpse of the in-depth analysis through our Report Brochure
The revenue of drug discovery is slated to witness huge leap from ~22% in 2019 and reach ~26% by the end of 2030 in the metagenomics market. Hence, research companies are adopting metagenomics medicine mapping systems in order to advance in the field of drug discovery. On the other hand, metagenomics is playing a pivotal role in the assessment of soil health and freshwater quality. These domains are broadening revenue streams for companies in the metagenomics market. Unprecedented environmental events and impact on the biodiversity are key drivers favoring market growth.
Apart from drug discovery and clinical diagnostics, companies in the metagenomics market are increasing their focus in food genomics in order to broaden their revenue streams. As such, food & beverages are estimated to dictate the third-highest revenue among all applications in the metagenomics market. The growing demand for safe food production and preservation is creating incremental opportunities for companies in the market for metagenomics.
Striking the right balance between food enzymes and microbes is becoming the key focus point for research labs and healthcare companies in order to ensure safe food production and preservation. Hence, companies are increasing their R&D activities in food microbiology. As stated by molecular biologist Dr. Nur Hasan from CosmosID - a leading next generation sequencing services company, placing together complex unassembled reads and the lack of comprehensive databases are some of the bottlenecks that researchers face in the field of food quality and safety. Hence, providers of end-to-end microbiome platforms are increasing efforts to develop integrated platforms with innovative bioinformatics tools that facilitate ultra-fast metagenomics analysis.
Expanding operations in future? To get the perfect launch ask for a custom report
Analysts’ Viewpoint
The automated placement of COVID-19 with closest known viruses is being made possible with next-gen metagenomics analysis platforms. Microbial ecologists in the metagenomics market are extensively using shotgun metagenomics to assess the microbial diversity in soil. However, limited sequence assembly from highly complex samples poses a bottleneck for microbial ecologists. Hence, companies should increase awareness about flow cytometry-enabled mini-metagenomics to help microbial ecologists capture expanded microbial diversity from forest soil.
Metagenomic sequencing holds potential in the diagnosis of neuroinfectious diseases. Bioinformatics technologies are being deployed for the study of plant-associated microbial communities. Integrated bioinformatics tools are playing a key role in meeting specificity requirements in food safety applications.
Metagenomics Market - Segmentation
|
Product Type |
Instruments Kits & Reagents Software & Services |
|
Technology |
16S Sequencing Whole Genome Sequencing Shotgun Sequencing Others |
|
Application |
Ecology & Environment Clinical Diagnostics Drug Discovery Biotechnology Food & Beverages Others |
|
Region |
North America Europe Asia Pacific Latin America Middle East & Africa |
Interested in this report?
Get a FREE Brochure now!
*Get Brochure Report (PDF) sent to your email within minutes
Metagenomics market to reach valuation of ~US$ 6.1 Bn by 2030
Metagenomics market is driven by the rise in prevalence of genetic, infectious, and other chronic diseases across globe
The instruments segment accounted for a notable share of the market, owing to the instruments used as a primary tools for conducting metagenomic study
North America accounted for a major share of the global metagenomics market
Key players in the global metagenomics market include Thermo Fisher Scientific, Inc., QIAGEN, Illumina, Inc., Promega Corporation, Novogene Co., Ltd.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Metagenomics Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Metagenomics Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Events and Developments
5.2. Major Research Institutes Involved
5.3. Pricing Analysis
5.4. Technological Advancements
5.5. COVID-19 Pandemic Impact on Global Metagenomics Market
6. Global Metagenomics Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Metagenomics Market Value Forecast, by Product Type, 2018–2030
6.3.1. Instruments
6.3.2. Kits & Reagents
6.3.3. Software & Services
6.4. Market Attractiveness Analysis, by Product Type
7. Global Metagenomics Market Analysis and Forecast, by Technology
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Metagenomics Market Value Forecast, by Technology, 2018–2030
7.3.1. 16S Sequencing
7.3.2. Whole Genome Sequencing
7.3.3. Shotgun Sequencing
7.3.4. Others
7.4. Global Metagenomics Market Attractiveness Analysis, by Technology
8. Global Metagenomics Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Metagenomics Market Value Forecast, by Application, 2018–2030
8.3.1. Ecology & Environment
8.3.2. Clinical Diagnostics
8.3.3. Drug Discovery
8.3.4. Biotechnology
8.3.5. Food & Beverage
8.3.6. Others
8.4. Global Metagenomics Market Attractiveness Analysis, by Application
9. Global Metagenomics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Metagenomics Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Metagenomics Market Attractiveness Analysis, by Region
10. North America Metagenomics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Metagenomics Market Value Forecast, by Product Type, 2018–2030
10.2.1. Instruments
10.2.2. Kits & Reagents
10.2.3. Software & Services
10.3. North America Metagenomics Market Value Forecast, by Technology, 2018–2030
10.3.1. 16S Sequencing
10.3.2. Whole Genome Sequencing
10.3.3. Shotgun Sequencing
10.3.4. Others
10.4. North America Metagenomics Market Value Forecast, by Application, 2018–2030
10.4.1. Ecology & Environment
10.4.2. Clinical Diagnostics
10.4.3. Drug Discovery
10.4.4. Biotechnology
10.4.5. Food & Beverage
10.4.6. Others
10.5. North America Metagenomics Market Value Forecast, by Country, 2018–2030
10.5.1. U.S.
10.5.2. Canada
10.6. North America Metagenomics Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Technology
10.6.3. By Application
10.6.4. By Country
11. Europe Metagenomics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Metagenomics Market Value Forecast, by Product Type, 2018–2030
11.2.1. Instruments
11.2.2. Kits & Reagents
11.2.3. Software & Services
11.3. Europe Metagenomics Market Value Forecast, by Technology, 2018–2030
11.3.1. 16S Sequencing
11.3.2. Whole Genome Sequencing
11.3.3. Shotgun Sequencing
11.3.4. Others
11.4. Europe Metagenomics Market Value Forecast, by Application, 2018–2030
11.4.1. Ecology & Environment
11.4.2. Clinical Diagnostics
11.4.3. Drug Discovery
11.4.4. Biotechnology
11.4.5. Food & Beverage
11.4.6. Others
11.5. Europe Metagenomics Market Value Forecast, by Country/Sub-region, 2018–2030
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Metagenomics Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Technology
11.6.3. By Application
11.6.4. By Country/Sub-region
12. Asia Pacific Metagenomics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Metagenomics Market Value Forecast, by Product Type, 2018–2030
12.2.1. Instruments
12.2.2. Kits & Reagents
12.2.3. Software & Services
12.3. Asia Pacific Metagenomics Market Value Forecast, by Technology, 2018–2030
12.3.1. 16S Sequencing
12.3.2. Whole Genome Sequencing
12.3.3. Shotgun Sequencing
12.3.4. Others
12.4. Asia Pacific Metagenomics Market Value Forecast, by Application, 2018–2030
12.4.1. Ecology & Environment
12.4.2. Clinical Diagnostics
12.4.3. Drug Discovery
12.4.4. Biotechnology
12.4.5. Food & Beverage
12.4.6. Others
12.5. Asia Pacific Metagenomics Market Value Forecast, by Country/Sub-region, 2018–2030
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Metagenomics Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Technology
12.6.3. By Application
12.6.4. By Country/Sub-region
13. Latin America Metagenomics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Metagenomics Market Value Forecast, by Product Type, 2018–2030
13.2.1. Instruments
13.2.2. Kits & Reagents
13.2.3. Software & Services
13.3. Latin America Metagenomics Market Value Forecast, by Technology, 2018–2030
13.3.1. 16S Sequencing
13.3.2. Whole Genome Sequencing
13.3.3. Shotgun Sequencing
13.3.4. Others
13.4. Latin America Metagenomics Market Value Forecast, by Application, 2018–2030
13.4.1. Ecology & Environment
13.4.2. Clinical Diagnostics
13.4.3. Drug Discovery
13.4.4. Biotechnology
13.4.5. Food & Beverage
13.4.6. Others
13.5. Latin America Metagenomics Market Value Forecast, by Country/Sub-region, 2018–2030
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Metagenomics Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Technology
13.6.3. By Application
13.6.4. By Country/Sub-region
14. Middle East & Africa Metagenomics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Metagenomics Market Value Forecast, by Product Type, 2018–2030
14.2.1. Instruments
14.2.2. Kits & Reagents
14.2.3. Software & Services
14.3. Middle East & Africa Metagenomics Market Value Forecast, by Technology, 2018–2030
14.3.1. 16S Sequencing
14.3.2. Whole Genome Sequencing
14.3.3. Shotgun Sequencing
14.3.4. Others
14.4. Middle East & Africa Metagenomics Market Value Forecast, by Application, 2018–2030
14.4.1. Ecology & Environment
14.4.2. Clinical Diagnostics
14.4.3. Drug Discovery
14.4.4. Biotechnology
14.4.5. Food & Beverage
14.4.6. Others
14.5. Middle East & Africa Metagenomics Market Value Forecast, by Country/Sub-region, 2018–2030
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Metagenomics Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Technology
14.6.3. By Application
14.6.4. By Country/Sub-region
15. Competitive Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Company Profiles
15.2.1. Thermo Fisher Scientific, Inc.
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Financial Overview
15.2.1.3. Product Portfolio
15.2.1.4. Strategic Overview
15.2.1.5. SWOT Analysis
15.2.2. QIAGEN
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Financial Overview
15.2.2.3. Product Portfolio
15.2.2.4. Strategic Overview
15.2.2.5. SWOT Analysis
15.2.3. Illumina, Inc.
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Financial Overview
15.2.3.3. Product Portfolio
15.2.3.4. Strategic Overview
15.2.3.5. SWOT Analysis
15.2.4. Promega Corporation
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Product Portfolio
15.2.4.3. Strategic Overview
15.2.4.4. SWOT Analysis
15.2.5. Novogene Co., Ltd.
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. Strategic Overview
15.2.5.4. SWOT Analysis
15.2.6. Takara Bio, Inc.
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Financial Overview
15.2.6.3. Product Portfolio
15.2.6.4. Strategic Overview
15.2.6.5. SWOT Analysis
15.2.7. Oxford Nanopore Technologies
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Product Portfolio
15.2.7.3. Strategic Overview
15.2.7.4. SWOT Analysis
15.2.8. Arc Bio, LLC.
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Product Portfolio
15.2.8.3. Strategic Overview
15.2.8.4. SWOT Analysis
15.2.9. Eurofins Scientific
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Financial Overview
15.2.9.3. Product Portfolio
15.2.9.4. Strategic Overview
15.2.9.5. SWOT Analysis
15.2.10. Zymo Research
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Product Portfolio
15.2.10.3. Strategic Overview
15.2.10.4. SWOT Analysis
15.2.11. Microsynth AG
15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.11.2. Product Portfolio
15.2.11.3. Strategic Overview
15.2.11.4. SWOT Analysis
15.2.12. F. Hoffmann-La Roche Ltd. (Roche Sequencing)
15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.12.2. Financial Overview
15.2.12.3. Product Portfolio
15.2.12.4. Strategic Overview
15.2.12.5. SWOT Analysis
15.2.13. PerkinElmer, Inc.
15.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.13.2. Financial Overview
15.2.13.3. Product Portfolio
15.2.13.4. Strategic Overview
15.2.13.5. SWOT Analysis
15.2.14. Computomics GmbH
15.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.14.2. Product Portfolio
15.2.14.3. Strategic Overview
15.2.14.4. SWOT Analysis
List of Tables
Table: 1 Global Metagenomics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
Table: 2 Global Metagenomics Market Value (US$ Mn) Forecast, by Technology, 2018-2030
Table: 3 Global Metagenomics Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table: 4 Global Metagenomics Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table: 5 North America Metagenomics Market Value (US$ Mn) Forecast, by Country, 2018?2030
Table: 6 North America Metagenomics Market Value (US$ Mn) Forecast, by Product Type, 2018?2030
Table: 7 North America Metagenomics Market Value (US$ Mn) Forecast, by Technology, 2018?2030
Table: 8 North America Metagenomics Market Value (US$ Mn) Forecast, by Application, 2018?2030
Table: 9 Europe Metagenomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018?2030
Table: 10 Europe Metagenomics Market Value (US$ Mn) Forecast, by Product Type, 2018?2030
Table: 11 Europe Metagenomics Market Value (US$ Mn) Forecast, by Technology, 2018?2030
Table: 12 Europe Metagenomics Market Value (US$ Mn) Forecast, by Application, 2018?2030
Table: 13 Asia Pacific Metagenomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018?2030
Table: 14 Asia Pacific Metagenomics Market Value (US$ Mn) Forecast, by Product Type, 2018?2030
Table: 15 Asia Pacific Metagenomics Market Value (US$ Mn) Forecast, by Technology, 2018?2030
Table: 16 Asia Pacific Metagenomics Market Value (US$ Mn) Forecast, by Application, 2018?2030
Table: 17 Latin America Metagenomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018?2030
Table: 18 Latin America Metagenomics Market Value (US$ Mn) Forecast, by Product Type, 2018?2030
Table: 19 Latin America Metagenomics Market Value (US$ Mn) Forecast, by Technology, 2018?2030
Table: 20 Latin America Metagenomics Market Value (US$ Mn) Forecast, by Application, 2018?2030
Table: 21 Middle East & Africa Metagenomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018?2030
Table: 22 Middle East & Africa Metagenomics Market Value (US$ Mn) Forecast, by Product Type, 2018?2030
Table: 23 Middle East & Africa Metagenomics Market Value (US$ Mn) Forecast, by Technology, 2018?2030
Table: 24 Middle East & Africa Metagenomics Market Value (US$ Mn) Forecast, by Application, 2018?2030
List of Figures
Figure: 1 Global Metagenomics Market Value (US$ Mn) and Y-o-Y (%) Forecast, 2018–2030
Figure: 2 Global Metagenomics Market Value Share, by Product Type, 2019
Figure: 3 Global Metagenomics Market Value Share, by Technology, 2019
Figure: 4 Global Metagenomics Market Value Share, by Region, 2019
Figure: 5 Global Metagenomics Market Value Share, by Application , 2019
Figure: 6 Global Metagenomics Market Value Share Analysis, by Product Type, 2019 and 2030
Figure: 7 Global Metagenomics Market Attractiveness Analysis, by Product Type, 2020–2030
Figure: 8 Global Metagenomics Market Value (US$ Mn) and Y-o-Y Growth (%), by Instruments, 2020–2030
Figure: 9 Global Metagenomics Market Value (US$ Mn) and Y-o-Y Growth (%), by Kits & Reagents, 2020–2030
Figure: 10 Global Metagenomics Market Value (US$ Mn) and Y-o-Y Growth (%), by Software & Services, 2020–2030
Figure: 11 Global Metagenomics Market Value Share Analysis, by Technology, 2019 and 2030
Figure: 12 Global Metagenomics Market Attractiveness Analysis, by Technology, 2020–2030
Figure: 13 Global Metagenomics Market Value (US$ Mn) and Y-o-Y Growth (%), by 16S Sequencing, 2020–2030
Figure: 14 Global Metagenomics Market value (US$ Mn) and Y-o-Y Growth (%), by Whole Genome Sequencing, 2020–2030
Figure: 15 Global Metagenomics Market Value (US$ Mn) and Y-o-Y Growth (%), by Shotgun Sequencing, 2020–2030
Figure: 16 Global Metagenomics Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2020–2030
Figure: 17 Global Metagenomics Market Value Share Analysis, by Application, 2019 and 2030
Figure: 18 Global Metagenomics Market Attractiveness Analysis, by Application, 2020–2030
Figure: 19 Global Metagenomics Market Value (US$ Mn) and Y-o-Y Growth (%), by Ecology & Environment, 2020–2030
Figure: 20 Global Metagenomics Market value (US$ Mn) and Y-o-Y Growth (%), by Clinical Diagnostics, 2020–2030
Figure: 21 Global Metagenomics Market Value (US$ Mn) and Y-o-Y Growth (%), by Drug Discovery, 2020–2030
Figure: 22 Global Metagenomics Market Value (US$ Mn) and Y-o-Y Growth (%), by Biotechnology, 2020–2030
Figure: 23 Global Metagenomics Market Value (US$ Mn) and Y-o-Y Growth (%), by Food & Beverage, 2020–2030
Figure: 24 Global Metagenomics Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2020–2030
Figure: 25 Global Metagenomics Market Value Share Analysis, by Region, 2019 and 2030
Figure: 26 Global Metagenomics Market Attractiveness Analysis, by Region, 2020–2030
Figure: 27 North America Metagenomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018?2030
Figure: 28 North America Metagenomics Market Value Share Analysis, by Country, 2019 and 2030
Figure: 29 North America Metagenomics Market Attractiveness Analysis, by Country, 2020–2030
Figure: 30 North America Metagenomics Market Value Share Analysis, by Product Type, 2019 and 2030
Figure: 31 North America Metagenomics Market Attractiveness Analysis, by Product Type, 2020–2030
Figure: 32 North America Metagenomics Market Value Share Analysis, by Technology, 2019 and 2030
Figure: 33 North America Metagenomics Market Attractiveness Analysis, by Technology, 2020–2030
Figure: 34 North America Metagenomics Market Value Share Analysis, by Application, 2019 and 2030
Figure: 35 North America Metagenomics Market Attractiveness Analysis, by Application, 2020–2030
Figure: 36 Europe Metagenomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018?2030
Figure: 37 Europe Metagenomics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure: 38 Europe Metagenomics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure: 39 Europe Metagenomics Market Value Share Analysis, by Product Type, 2019 and 2030
Figure: 40 Europe Metagenomics Market Attractiveness Analysis, by Product Type, 2020–2030
Figure: 41 Europe Metagenomics Market Value Share Analysis, by Technology, 2019 and 2030
Figure: 42 Europe Metagenomics Market Attractiveness Analysis, by Technology, 2020–2030
Figure: 43 Europe Metagenomics Market Value Share Analysis, by Application, 2019 and 2030
Figure: 44 Europe Metagenomics Market Attractiveness Analysis, by Application, 2020–2030
Figure: 45 Asia Pacific Metagenomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018?2030
Figure: 46 Asia Pacific Metagenomics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure: 47 Asia Pacific Metagenomics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure: 48 Asia Pacific Metagenomics Market Value Share Analysis, by Product Type, 2019 and 2030
Figure: 49 Asia Pacific Metagenomics Market Attractiveness Analysis, by Product Type, 2020–2030
Figure: 50 Asia Pacific Metagenomics Market Value Share Analysis, by Technology, 2019 and 2030
Figure: 51 Asia Pacific Metagenomics Market Attractiveness Analysis, by Technology, 2020–2030
Figure: 52 Asia Pacific Metagenomics Market Value Share Analysis, by Application, 2019 and 2030
Figure: 53 Asia Pacific Metagenomics Market Attractiveness Analysis, by Application, 2020–2030
Figure: 54 Latin America Metagenomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018?2030
Figure: 55 Latin America Metagenomics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure: 56 Latin America Metagenomics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure: 57 Latin America Metagenomics Market Value Share Analysis, by Product Type, 2019 and 2030
Figure: 58 Latin America Metagenomics Market Attractiveness Analysis, by Product Type, 2020–2030
Figure: 59 Latin America Metagenomics Market Value Share Analysis, by Technology, 2019 and 2030
Figure: 60 Latin America Metagenomics Market Attractiveness Analysis, by Technology, 2020–2030
Figure: 61 Latin America Metagenomics Market Value Share Analysis, by Application, 2019 and 2030
Figure: 62 Latin America Metagenomics Market Attractiveness Analysis, by Application, 2020–2030
Figure: 63 Middle East & Africa Metagenomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018?2030
Figure: 64 Middle East & Africa Metagenomics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure: 65 Middle East & Africa Metagenomics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure: 66 Middle East & Africa Metagenomics Market Value Share Analysis, by Product Type, 2019 and 2030
Figure: 67 Middle East & Africa Metagenomics Market Attractiveness Analysis, by Product Type, 2020–2030
Figure: 68 Middle East & Africa Metagenomics Market Value Share Analysis, by Technology, 2019 and 2030
Figure: 69 Middle East & Africa Metagenomics Market Attractiveness Analysis, by Technology, 2020–2030
Figure: 70 Middle East & Africa Metagenomics Market Value Share Analysis, by Application, 2019 and 2030
Figure: 71 Middle East & Africa Metagenomics Market Attractiveness Analysis, by Application, 2020–2030
Figure: 72 Global Metagenomics Market Share Analysis, by Company (2019)
Figure: 73 Thermo Fisher Scientific, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Figure: 74 Thermo Fisher Scientific, Inc. Breakdown of Net Sales, by Business Segments (%), 2019
Figure: 75 Thermo Fisher Scientific, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Figure: 76 QIAGEN Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Figure: 77 QIAGEN Breakdown of Net Sales (%), by Region/Country, 2019
Figure: 78 QIAGEN Revenue Breakdown of Net Sales (%), by Segment, 2019
Figure: 79 QIAGEN R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Figure: 80 Illumina, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2019
Figure: 81 Illumina, Inc. Breakdown of Net Sales (%), by Region/Country, 2019
Figure: 82 Illumina, Inc. Revenue Breakdown of Net Sales (%), by Segment, 2019
Figure: 83 Illumina, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2019
Figure: 84 Takara Bio Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure: 85 Takara Bio Inc. Breakdown of Net Sales (%), by Region/Country, 2020
Figure: 86 Takara Bio Inc. Revenue Breakdown of Net Sales (%), by Segment, 2020
Figure: 87 Takara Bio Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure: 88 Eurofins Scientific Breakdown of Net Sales (%), by Region/Country, 2020
Figure: 89 Eurofins Scientific Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Figure: 90 F. Hoffmann-La Roche Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Figure: 91 F. Hoffmann-La Roche Ltd. Breakdown of Net Sales (%), by Region, 2019
Figure: 92 F. Hoffmann-La Roche Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Figure: 93 F. Hoffmann-La Roche Ltd. Breakdown of Net Sales (%), by Business Segment, 2019
Figure: 94 PerkinElmer, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2019
Figure: 95 PerkinElmer, Inc. Breakdown of Net Sales (%), by Region, 2019
Figure: 96 PerkinElmer, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2019
Figure: 97 PerkinElmer, Inc. Breakdown of Net Sales (%), by Business Segment,2019
Complete the form below and we'll get back to you shortly.
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
